当前位置：
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Aptamers as targeted therapeutics: current potential and challenges
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-04-28 00:00:00 , DOI: 10.1038/nrd.2017.86 Jiehua Zhou , John Rossi
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-04-28 00:00:00 , DOI: 10.1038/nrd.2017.86 Jiehua Zhou , John Rossi
Nature Reviews Drug Discovery16, 181–202 (2017)Base Pair Biotechnologies and Apterna were omitted from Table 3 in this article. These have now been included.
中文翻译：
适体作为靶向治疗剂：当前的潜力和挑战
Nature Reviews Drug Discovery16，181–202（2017）本文表3省略了碱基对生物技术和Apterna。这些现已包括在内。
更新日期：2017-05-31
中文翻译：
适体作为靶向治疗剂：当前的潜力和挑战
Nature Reviews Drug Discovery16，181–202（2017）本文表3省略了碱基对生物技术和Apterna。这些现已包括在内。
京公网安备 11010802027423号